Investegate |Hikma Pharmaceutical Announcements | Hikma Pharmaceutical: Hikma launches generic Advair Diskus
London, 17 December 2020 - Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, annou nces it has received FDA approval for and launched its generic version of GlaxoSmithKline's Advair Diskus ®1 (Fluticasone Propionate and Salmeterol Inhalation Powder, USP), 100mcg/50mcg and 250mcg/50mcg doses in the US. Hikma worked with Vectura Group, a UK based provider of innovative inhaler drug delivery solutions, to develop the proprietary dry powder inhaler and formulation technology. Acco...
Source: investegate.co.uk